
Milibact 500mg/250mg Injection
Marketer
Glenmark Pharmaceuticals Ltd
Salt Composition
Ceftriaxone (500mg) + Sulbactam (250mg)
Overview Milibact 500mg/250mg Injection
Combiflox 500mg/250mg Injection is a dual-action antibiotic indicated for diverse bacterial infections. Its mechanism combats microbial proliferation, thereby halting infection progression. Administration must be strictly under a doctor's guidance; adhere to all scheduled doses. Complete the prescribed course, regardless of symptom improvement; premature cessation may compromise efficacy. Commonly reported side effects include nausea, vomiting, diarrhea, and dyspepsia. Escalating side effects necessitate immediate medical consultation. Seek immediate medical attention for allergic reactions (rash, pruritus, edema, dyspnea, etc.). Disclose all current medications to your physician prior to commencement. Pregnant or lactating individuals require prior medical approval. Alcohol consumption should be avoided due to potential additive drowsiness. While generally non-impairing to driving ability, refrain from operating vehicles if drowsiness or dizziness occurs. Adequate rest, balanced nutrition, and sufficient hydration are crucial for optimal recovery. Your doctor may order laboratory and imaging tests to monitor treatment response.
Uses of Milibact 500mg/250mg Injection
Infections caused by bacteria
Major Benefits of Milibact 500mg/250mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strongly discouraged.
Common Side effects of Milibact 500mg/250mg Injection:
- Increased white blood cell count (eosinophils)
- Decreased white blood cell count (lymphocytes)
- Low blood platelets
- Rash
- Diarrhea
- Increased liver enzymes
- Injection site reactions (pain, swelling, redness)
How to use Milibact 500mg/250mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strongly discouraged.
How Milibact 500mg/250mg Injection works:
Ceftriaxone/Sulbactam 500mg/250mg Injection (Milibact) combines the antibiotic Ceftriaxone with the beta-lactamase inhibitor Sulbactam. Ceftriaxone's mechanism involves disrupting bacterial cell wall synthesis, hindering bacterial survival. Sulbactam counteracts bacterial resistance mechanisms, thereby bolstering Ceftriaxone's antibacterial efficacy.
SAFETY ADVICE
AlcoholSAFE
Ingestion of alcohol alongside Milibact 500 mg/250 mg Injection presents no known adverse reactions.
PregnancySAFE IF PRESCRIBED
The injectable medication Milibact 500 mg/250 mg is typically deemed safe for use during gestation. Preclinical trials in animals revealed minimal or absent harm to offspring; nevertheless, clinical data in humans are scarce.
Breast feedingCAUTION
The administration of Milibact 500 mg/250 mg Injection to breastfeeding mothers requires careful consideration. Nursing should be temporarily discontinued throughout the mother's treatment and until the medication is fully cleared from her system.
DrivingUNSAFE
The injection Milibact 500 mg/250 mg can induce drowsiness, blurred vision, and dizziness. Refrain from driving if you experience these effects.
KidneyCONSULT YOUR DOCTOR
Insufficient data exists regarding the administration of Milibact 500 mg/250 mg Injection to individuals with renal impairment. Physician consultation is advised.
LiverCAUTION
Exercise caution when administering Milibact 500 mg/250 mg Injection to individuals with severe hepatic impairment; dosage modification may be necessary. Consult a physician before administering. Dosage alteration for Milibact 500 mg/250 mg Injection is unnecessary in patients exhibiting mild to moderate liver dysfunction.
What if you forget to take Milibact 500mg/250mg Injection :
Should you forget a scheduled dose of Milibact 500 mg/250 mg Injection, seek advice from your physician.
Facts to Know About Milibact 500mg/250mg Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Antimicrobial Agents |
